SILK - Silk Road Medical, Inc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
41.70
+0.36 (+0.87%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close41.34
Open41.45
Bid41.54 x 800
Ask41.60 x 1400
Day's Range41.08 - 41.85
52 Week Range30.87 - 51.50
Volume120,690
Avg. Volume217,968
Market Cap1.279B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswirelast month

    ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile

    Final Results Presented in Late-Breaking Sessionat Society for Vascular Surgery 2019 Vascular Annual Meeting NATIONAL HARBOR, Md., June 15, 2019 -- Silk Road Medical, Inc..

  • GlobeNewswirelast month

    TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease

    Updated Results of TCAR Surveillance Project Presented at Society for Vascular Surgery Vascular Annual Meeting NATIONAL HARBOR, Md., June 13, 2019 -- Silk Road Medical, Inc..

  • GlobeNewswirelast month

    Silk Road Medical to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

    Silk Road Medical, Inc. (SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference in New York, NY. Silk Road Medical’s management is scheduled to present on Tuesday, June 25 at 10:40 a.m. Eastern Time.  Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/. Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact.

  • GlobeNewswire2 months ago

    Silk Road Medical Announces Key TCAR Presentations at the Society for Vascular Surgery 2019 Vascular Annual Meeting

    SUNNYVALE, Calif. , June 04, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key.

  • GlobeNewswire2 months ago

    Silk Road Medical Reports First Quarter 2019 Financial Results

    SUNNYVALE, Calif., May 08, 2019 -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial.

  • GlobeNewswire3 months ago

    Silk Road Medical to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

    Silk Road Medical, Inc. (SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, NV. Silk Road Medical’s management is scheduled to present on Wednesday, May 15 at 11:20 a.m. Pacific Time. Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact.

  • GlobeNewswire3 months ago

    Silk Road Medical to Report First Quarter 2019 Financial Results on May 8, 2019

    Silk Road Medical, Inc. (SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2019 after market close on Wednesday, May 8, 2019. Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 5758256. Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact.

  • GlobeNewswire3 months ago

    Silk Road Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

    Silk Road Medical, Inc. (SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing of its initial public offering of 6,000,000 shares of common stock, and the exercise in full of the underwriters’ option to purchase 900,000 additional shares of common stock from the selling stockholders, at a public offering price of $20 per share. The gross proceeds from the offering were approximately $120 million, before deducting underwriting discounts and commissions and estimated offering expenses.  Silk Road Medical did not receive any proceeds from the sale of the shares of common stock by the selling stockholders. J.P. Morgan Securities LLC and BofA Merrill Lynch acted as joint book-running managers for the offering.

  • GlobeNewswire4 months ago

    Silk Road Medical Announces Pricing of Initial Public Offering

    Silk Road Medical, Inc. (SILK) (“Silk Road Medical”) today announced the pricing of its initial public offering of 6,000,000 shares of common stock at a public offering price of $20.00 per share. All of the shares of common stock are being offered by Silk Road Medical. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.